In preparing guidelines for
dermatomycosis (
tinea, trichophytia,
dermatophytosis), we have primarily summarized the disease types and treatments as described in 4 textbooks used in Japan and abroad. We present our classification draft based on these following descriptions. In Japan, any
dermatophytosis other than
favus or
tinea imbricata is considered to be
tinea, while outside Japan,
favus and
tinea imbricata are also classified as
tinea.
Tinea capitis is classified together with trichophytia superficialis capillitii and
kerion celsi, in a group that tends to include asymptomatic carriers. Most textbooks generally classify trichophytia profunda of the glabrous skin and
granuloma trichophyticum as subtypes of
tinea corporis.
Tinea faciei can easily be misdiagnosed, but in many cases can be distinguished from
tinea corporis by its specific clinical picture.
Tinea unguium is regarded as one type of
onychomycosis. We present a summary of
dermatomycosis treatment as a proposal for future revision of the guidelines. One of the problems in the treatment of
tinea capitis is that the safety of
itraconazole (ITZ) and
terbinafine hydrochloride (TBF) in children has not been established. Severity criteria for concomitant use of oral medications in the treatment of
tinea pedis remains to should be established. Although many clinical studies concerning
tinea unguium have been published, 3 of the 4 textbooks we consulted clearly stated that most of those studies were conducted by pharmaceutical companies. Further studies on the etiology and disease severity of
tinea unguium are needed.